Denali Therapeutics Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.72 | $-0.68 | +5.6% | Beat |
| Q12026 FY2026 | $-0.73 | $-0.69 | +5.5% | Beat |
| Q42025 FY2025 | $-0.75 | $-0.73 | +2.7% | Beat |
Back to DNLI overview · DNLI holders · DNLI KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.